Schedule 13D ownership disclosure
ADVERUM BIOTECHNOLOGIES INC
Common Stock, par value $0.0001 per share · CUSIP: 00773U108
Event date: 2025-12-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BML Investment Partners, L.P.Reported CIK 0001373604
Shares: 0 · Class: 0%
- Leonard Braden MichaelReported CIK 0001373603
Shares: Unavailable · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000124
- Form type
- SCHEDULE 13D/A
- Filer
- Adverum Biotechnologies, Inc.
- CIK
- CIK 1501756
- Filed
- Dec 09, 2025
- Reporting period
- Dec 09, 2025
- Description
- Schedule 13D beneficial ownership